Introduction

 

DNA Synthesis

DNA is responsible for coding the majority of information required for life on earth, and is the biomolecule at the centre of the life sciences. DNA synthesis is the process by which we construct strands of DNA de novo, which is a vital step in processes from fundamental scientific research to generating life-saving drugs. Despite the importance of DNA synthesis, the technology used today is not vastly different from that used several decades ago - a paradigm challenged by Nuclera.

DNA synthesis

Technology

Nuclera technology
 

Nuclera Technology

The assembly of monomeric units into short oligomeric sequences is well-established, and is core to important technologies such as PCR and targeted enrichment. However, many functional elements of DNA are beyond the reach of current synthesis methods.

Nuclera is developing a next-generation DNA synthesis platform to enable the production of long, biologically relevant pieces of DNA. We aim to provide the life science community with rapid access to highly accurate functional DNA molecules, accelerating current research pipelines and enabling new opportunities. The ability to obtain designer DNA on demand allows us to not only better understand our world, but improve it.

Management

Management

Michael Chen

Michael Chen

Founder and CTO

Michael has eight years experience in academic research, from nucleic acid chemistry to protein expression and biophysical characterization, resulting in seven published papers. Alongside a key role in technology development, he ensures Nuclera's scientific strategy serves its business strategy. Michael holds a BSc in Chemistry from Georgia Institute of Technology, and will soon complete a PhD in Chemistry at the University of Cambridge.

Jiahao Huang

Jiahao Huang

Founder and CCO

A molecular biologist by trade, Jiahao has coordinated multi-national collaborative projects and experienced first hand the limitations of the current provision of DNA. This intimate knowledge of user requirements enable him to guide Nuclera's commercial operations towards creating the right product for the right market. Jiahao holds a BSc from the University of California, Berkley, and a PhD in Molecular Biology from the University of Cambridge.

Radu Lazar

Radu Lazar

Founder and CFO

Radu's scientific background in biomedical and chemical engineering, is bolstered by significant experience in management consultancy. He directs Nuclera's financial situation, and still finds time to contribute to development of instrumentation. Radu holds a BSc Eng from the University of Illinois, Urbana-Champaign, and a PhD in Chemical Engineering from the University of Cambridge.

Gordon McInroy

Gordon McInroy

Founder and CSO

Originally a synthetic chemist before moving into chemical biology, Gordon has extensive experience in applying chemical methodology to solve a wide range of problems. He is passionate about developing Nuclera's next-generation synthesis platform, to enable exciting new lines of research in the life sciences. Gordon holds an MSci in Natural Sciences and a PhD in Chemistry, both from the University of Cambridge.